Application of peptide barcoding to obtain high-affinity anti-PD-1 nanobodies

[1]  Yi Shi,et al.  Nanobodies: Robust Miniprotein Binders in Biomedicine. , 2023, Advanced drug delivery reviews.

[2]  Guangxian Xu,et al.  Screening and identification of an anti-PD-1 nanobody with antitumor activity , 2022, Bioscience reports.

[3]  Jian Li,et al.  Envafolimab – first PD-1/PD-L1 antibody to be administered by subcutaneous injection for microsatellite instability-high or deficient mismatch repair advanced solid tumors , 2022, Expert opinion on biological therapy.

[4]  M. Fukuyama,et al.  Reconstitution of ribosome self-replication outside a living cell , 2022, bioRxiv.

[5]  N. Vale,et al.  Dostarlimab: A Review , 2022, Biomolecules.

[6]  S. Chupradit,et al.  Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons , 2022, Cell Communication and Signaling.

[7]  Sonja Billerbeck,et al.  Oligo Pools as an Affordable Source of Synthetic DNA for Cost‐Effective Library Construction in Protein‐ and Metabolic Pathway Engineering , 2021, Chembiochem : a European journal of chemical biology.

[8]  Natsuko Miura,et al.  Peptide barcoding for one-pot evaluation of sequence–function relationships of nanobodies , 2021, Scientific Reports.

[9]  Xiao-mei Yang,et al.  A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine. , 2021, Cancer letters.

[10]  J. Arnall,et al.  Caplacizumab: an anti-von Willebrand factor antibody for the treatment of thrombotic thrombocytopenic purpura. , 2020, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[11]  François Keck,et al.  Handling biological sequences in R with the bioseq package , 2020, Methods in Ecology and Evolution.

[12]  M. Suarez‐Almazor,et al.  Immune-related adverse events of checkpoint inhibitors , 2020, Nature Reviews Disease Primers.

[13]  Yakun Wan,et al.  Blocking the PD-1-PD-L1 axis by a novel PD-1 specific nanobody expressed in yeast as a potential therapeutic for immunotherapy. , 2019, Biochemical and biophysical research communications.

[14]  Angus M. Sidore,et al.  DropSynth 2.0: high-fidelity multiplexed gene synthesis in emulsions , 2019, bioRxiv.

[15]  A. Kruve,et al.  Influence of the amino acid composition on the ionization efficiencies of small peptides. , 2019, Journal of mass spectrometry : JMS.

[16]  Natsuko Miura,et al.  Peptide barcoding for establishment of new types of genotype–phenotype linkages , 2019, PloS one.

[17]  R. Rabadán,et al.  Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma , 2019, Nature Medicine.

[18]  Frank Klont,et al.  Assessment of Sample Preparation Bias in Mass Spectrometry-Based Proteomics , 2018, Analytical chemistry.

[19]  M. Xian,et al.  Recent advances in the selection and identification of antigen‐specific nanobodies , 2018, Molecular immunology.

[20]  Christian Panse,et al.  Engineered Peptide Barcodes for In-Depth Analyses of Binding Protein Ensembles , 2018, bioRxiv.

[21]  Jia Gu,et al.  fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.

[22]  Conor McMahon,et al.  Yeast surface display platform for rapid discovery of conformationally selective nanobodies , 2018, Nature Structural & Molecular Biology.

[23]  Masaki Matsumoto,et al.  jPOSTrepo: an international standard data repository for proteomes , 2016, Nucleic Acids Res..

[24]  Chris Sander,et al.  Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome , 2016, Cell.

[25]  Conrad von Schubert,et al.  Evaluation and Improvement of Quantification Accuracy in Isobaric Mass Tag-Based Protein Quantification Experiments. , 2016, Journal of proteome research.

[26]  Ulrich Bodenhofer,et al.  msa: an R package for multiple sequence alignment , 2015, Bioinform..

[27]  C. Drake,et al.  Immune checkpoint blockade: a common denominator approach to cancer therapy. , 2015, Cancer cell.

[28]  David Fenyö,et al.  A robust pipeline for rapid production of versatile nanobody repertoires , 2014, Nature Methods.

[29]  Edward M. Marcotte,et al.  Proteomic Identification of Monoclonal Antibodies from Serum , 2014, Analytical chemistry.

[30]  Rodrigo Lopez,et al.  Analysis Tool Web Services from the EMBL-EBI , 2013, Nucleic Acids Res..

[31]  K. Stejskal,et al.  Suppression of peptide sample losses in autosampler vials. , 2013, Journal of proteome research.

[32]  Sindy K. Y. Tang,et al.  Diversity of Phage-Displayed Libraries of Peptides during Panning and Amplification , 2011, Molecules.

[33]  J. Kolkman,et al.  Nanobodies - from llamas to therapeutic proteins. , 2010, Drug discovery today. Technologies.

[34]  G. Weiss,et al.  Phage wrapping with cationic polymers eliminates nonspecific binding between M13 phage and high pI target proteins. , 2009, Journal of the American Chemical Society.

[35]  K. Kuroda,et al.  Enhancement of display efficiency in yeast display system by vector engineering and gene disruption , 2009, Applied Microbiology and Biotechnology.

[36]  D. Neville,et al.  A new yeast display vector permitting free scFv amino termini can augment ligand binding affinities. , 2005, Protein engineering, design & selection : PEDS.

[37]  John C Chaput,et al.  Evolutionary optimization of a nonbiological ATP binding protein for improved folding stability. , 2004, Chemistry & biology.

[38]  Yoshimasa Tanaka,et al.  Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Haidong Dong,et al.  Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.

[40]  G. Freeman,et al.  Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.

[41]  S. Muyldermans,et al.  Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. , 1994, Protein engineering.

[42]  S. Muyldermans,et al.  Naturally occurring antibodies devoid of light chains , 1993, Nature.

[43]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[44]  S. Salzberg,et al.  FLASH: fast length adjustment of short reads to improve genome assemblies , 2011, Bioinform..